MR-ProADM Risk Score Calculator
Biomarker assessment
Enter the measured mid-regional pro-adrenomedullin (MR-proADM) concentration.
About MR-proADM
Mid-regional pro-adrenomedullin (MR-proADM) is a stable fragment of the adrenomedullin precursor. Concentrations may reflect endothelial dysfunction and severity of illness, and have been investigated for risk assessment in patients with suspected infection and sepsis.
Published studies use different thresholds depending on the population and outcome. The values shown here are evidence-informed reference bands, not universally validated categories of mortality risk.
Reference thresholds used in this tool
| Concentration | Evidence context | How to interpret |
|---|---|---|
| <0.87 nmol/L | Studied as a lower-risk threshold in suspected-infection emergency-department cohorts. | May support—but cannot independently determine—lower-risk triage. |
| 0.87 to <1.54 nmol/L | Between two thresholds reported in progression-risk research. | No universal risk percentage is assigned to this interval. |
| ≥1.54 nmol/L | Associated with increased disease progression risk in a multicentre derivation/validation study. | Consider with clinical findings and validated severity tools. |
Important limitations
- MR-proADM is an adjunct and must not replace clinical assessment or established sepsis pathways.
- Do not infer a fixed mortality percentage or ICU requirement from these bands alone.
- Thresholds may not transfer directly across assay platforms, populations, or clinical settings.
- Urgent signs of deterioration require immediate clinical evaluation regardless of the biomarker value.
References
Clinical notes
Document key findings and keep a structured record for your own reference.
My notes
Review, edit, or remove notes saved in this browser.
Report an issue
Your feedback helps us improve the reliability and usability of this clinical tool.